P activated platelets release a variety of proteins and other substances that presumably play roles in the arrest of bleeding and in the tissue remodeling associated with wound healing. Based on our that released thrombospondin (Tsp) undergoes intramolecular and intermolecular thiol-disulfide exchange and the reduction of one disulfide bond, we hypothesized the release of an enzyme to catalyze these reactions. Protein disulfide isomerase (PDI) (for reviews of PDI see refs 7 and 8) catalyzes the isomerization of disulfide bonds in proteins from one cys-cys pairing to a n~t h e r ,~ and it catalyzes the disulfide cross-linking of two polypeptide c h a i n~.~J~ PDI also exhibits protein thiol-disulfide oxidoreductase activity11J2; it catalyzes either the oxidation of thiols to disulfide bonds or the reduction of disulfide bonds to thiols, depending on the relative redox potentials of the proteins and other thiol/ disulfide pairs in the medium.
In this paper we report that a protein with PDI activity is released by activated platelets. The importance of this observation is that disulfide isomerization at the site of an injury raises many intriguing possibilities, including modification of the function of proteins by reduction or isomerization of disulfide bonds and the covalent cross-linking of proteins to each other and to cells.
MATERIALS AND METHODS
PDI assay. PDI activity was assayed by measurement of the renaturation of ribonuclease (RNase) that had been inactivated by formation of randomly mismatched, or "scrambled," disulfide bond^^,^,'^; such an RNase is referred to as scrambled RNase. In inhibited formation of disulfide-linked thrombospondinthrombin complexes. The reaction catalyzed by the supernatant solution showed a pH dependence distinct from that of the uncatalyzed reaction. The activity was excluded by a 50-Kd dialysis membrane, and it was eluted in the void volume of a gel-filtration column, indicating that it was associated with a macromolecule. The activity was not removed by centrifugation at lO0,OOOg for 150 minutes indicating that it was not associated with membrane microvesicles. Possible functions for the release of protein disulfide isomerase by activated platelets are discussed. Washed human platelets were obtained from blood of healthy volunteers by venipuncture. Blood was collected into 0.15 vol of anticoagulant containing 85 mmol/L sodium citrate, 65 mmol/L citric acid, and 1% glucose. Subsequent procedures were at 4°C. The blood was centrifuged at 300g for 20 minutes to obtain platelet-rich plasma, which was centrifuged at 1, OOOg for 20 minutes to sediment the platelets. The platelets were washed twice by resuspension in a solution containing 10 mmol/L HEPES (pH 7.4), 150 mmol/L NaCI, and 1 mmol/L EDTA. A final suspension in this solution contained 1 to 3 x lo9 platelets/mL. Platelets were activated at 37°C by addition of 2.5 mmol/L CaC12 and 2.5 Fmol/L calcium ionophore A23187 to the suspension. After 2.5 minutes, the suspension was centrifuged at 39,OOOg for 30 minutes to obtain the supernatant solution of activated platelets.
Human a-thrombin was a generous gift from John W. Fenton I1 (Wadsworth Cepter for Laboratories and Research, School of Public Health Sciences, New York Department of Health, Albany). The iodination of thrombin and the electrophoretic analysis of its complexes with Tsp have been described.* A23187 was purchased from Calbiochem (San Diego, CA). Antithrombin 111, somatostatin, and tocinoic acid were purchased from Sigma (St Louis, MO). Bacitracin A, prepared from bacitracin by chromatography, was a generous gift of Leo Kesner (Department of Biochemistry, SUNY Health Science Center at Brooklyn).
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RESULTS AND DISCUSSION
Acceleration of the rate of renaturation of scrambled RNase by the supernatant solution of A23187-activated platelets is shown in Fig 1A. Activity in the supernatant solution before activation of the platelets was negligible if (Fig lA, triangles) . The activity was inhibited by three peptides known to inhibit endoplasmic reticulum PDI1416 (Fig 1B) . The catalyzed renaturation showed a pH dependence distinct from the uncatalynzed renaturation (Fig 2) . The activity was not dialyzable through a 50-Kd cutoff membrane, and it was eluted from a Sephadex G-200 (Pharmacia-LKB, Piscataway, NJ) column in the void volume (data not shown), both suggesting that it was associated with a large macromolecule. We conclude that activated platelets release a macromolecule, presumably a protein, with PDI activity.
We hypothesized the release of PDI from platelets on the basis of three phenomena observed with Tsp in the supematant solution of activated platelets. First, complexes of thrombin with certain serpins become disulfide linked to T S P~,~ and Tsp becomes disulfide linked into multimers6 by processes that require free thiols. The most likely mechanism is thiol-disulfide exchange leading to a new intermolecular disulfide bond. Second, Tsp has one equivalent of thiol per polypeptide chain, but at least 12 different cysteinyl residues were labeled with a thiol-reactive reagent: indicating that there was isomerization of disulfide bond pairings. This is likely due to intramolecular thiol-disulfide exchange. Third, incubation of the supernatant solution led to an increase of nearly two thiols per mole of Tsp? indicating reduction of a disulfide bond. Because each of these three reactions is typical of one catalyzed by PDI,7,8 we tested the effect of bacitracin A, a PDI inhibitor1416 (Fig lB) , on one of them, the disulfide bonding of Tsp to thrombin-AT111 complexes. (In unpublished experiments by A.C. Chang and T.C. Detwiler, it has been shown that thrombin becomes disulfide linked to Tsp when it is complexed with ATIII as well as when it is complexed with released platelet protease nexin. The reactions require the supematant solution.) Formation of the complexes was inhibited by bacitracin A (Fig 3) . This suggests that PDI is responsible for the reaction, but this must be qualified by the fact that the mechanism by which bacitracin A inhibits PDI is unknown. A more difinitive test will require a pure enzyme or specific antibodies.
The best-studied protein disulfide isomerase is membrane associated7.8 as an enzyme of the endoplasmic reticulum, where it functions in post translational modification of proteins. Because A23187-activated platelets are known to release membrane micro vesicle^,^^^^^ we asked whether the released PDI activity was membrane associated. However, the activity in the supematant solution was not removed by centrifugation at 100,OOOg for 150 minutes, a condition that removes platelet microvesicles. There are proteins with PDI activity that are not associated with membranes; they include t h i o r e d o~i n~~~~~ and the peptide hormones lutropin and follitropin.zl One can imagine many possible roles for PDI at a site of injury, where platelets are activated. It was proposed, for example, that the intramolecular isomerization of disulfide bonds of thombospondin reflected a change in conformation when Tsp went from the a-granule to the extracellular medium? In this regard, the preliminary reportzz that the cell adhesive activity of thrombospondin depends on the state of disulfide bonds is especially interesting; it suggests that the cell adhesive properties of Tsp might depend on PDI. PDI might also catalyze the covalent cross-linking of matrix proteins or the covalent immobilization of biologically active molecules to the extracellular matrix. 
